By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investment firm Rodman & Renshaw has upgraded Sequenom's stock to "Market Perform" from "Market Underperform" following yesterday's publication by the San Diego-based firm of results on its non-invasive fetal trisomy 21 test.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers describe a way to share data while keeping it secure, Agence France Presse reports.
A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.
In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.
India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.
This webinar will address a range of methods for optimizing small RNA library preparation.
With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.
This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.